$KDP

Analysts upgraded Etsy (ETSY) to Buy with a $105 target, citing improved growth. Analog Devices (ADI) was upgraded by Seaport and Bernstein, with targets of $425 and $465, respectively, due to AI opportunities. Merck (MRK) was upgraded by Morgan Stanley to Overweight with a $179 target, but downgraded by RBC to Sector Perform with a $150 target. Progressive (PGR) was upgraded to Outperform with a $250 target, while Allstate (ALL) was downgraded to Underperform with a $250 target. TJX (TJX) was d

JDE Peet’s, part of Keurig Dr Pepper, has formed the Coffee Canopy Partnership with other coffee companies and Airbus to create a global map of coffee production using Airbus’s satellite technology. The goal is to prevent deforestation by identifying forest loss and empowering farmers with data. The pilot project in East Africa aims to map 1.2 million square kilometers by June 2026, with worldwide coverage targeted for 2027.

Keurig Dr Pepper (NASDAQ:KDP) reported Q2 results of $7.31B sales, $0.04 EPS, and $210M net income, beating estimates. The April 1 JDE Peet’s deal boosted coffee brands and LRB volumes, with LRB volumes up 2.8% in Q2. KDP also named Aaron Alt as an independent director and launched limited-time co-branded Dr Pepper shakes with Portillo’s.

Keurig Dr Pepper (NasdaqGS:KDP) announced a brand refresh for 7UP, its first in over 15 years, including a lime-focused recipe and updated visuals. The relaunch is backed by a marketing push targeting younger consumers. KDP also plans limited-time co-branded Dr Pepper Shake and Dr Pepper Cake Shake items via a Portillo’s partnership.

Coffee futures have risen about 13% over three months, outperforming SMH (+2.2%) and the S&P 500 (+4.1% since mid-May), despite record production, according to the article. Jefferies cites a ~30% arabica rebound since June and uncertainty after a Colombia earthquake. HSBC upgraded Keurig Dr Pepper to buy, raising its target to $40 from $37. The article also highlights Starbucks’ YTD +29% and a $125 target.

HSBC upgraded Keurig Dr Pepper (KDP) from Hold to Buy, citing strong trends in refreshment beverages and improving conditions, according to the firm. Shares rose about 4.0% in late Thursday morning trading, reflecting the rating change.

Keurig Dr Pepper (KDP) appointed Cardinal Health CFO Aaron Alt to its board as it prepares to split into two independent businesses, according to the article. It cites recent share performance and a “fair value” estimate of $35.65 versus a $29.56 close, implying about 17% upside, with risks from U.S. coffee trends and higher input costs.

HSBC upgraded Keurig Dr Pepper to Buy from Hold and raised its price target to $40 from $37, according to the bank. The article also notes Keurig Dr Pepper appointed Aaron Alt as a director effective Aug. 14, 2026.

Jefferies maintained a Hold rating on Keurig Dr Pepper (KDP) and a Buy rating on J.M. Smucker (SJM), citing arabica coffee prices up about 30% since June. Jefferies said prices rebounded sharply in the past two months after an earlier expectation of a tailwind. An earthquake in Colombia disrupted a key export road, adding uncertainty.

Keurig Dr Pepper Inc. (KDP) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. kdp-20260810 0001418135 FALSE 0001418135 2026-08-10 2026-08-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):